104919-70-2

Basic information

• Product Name: Carbamic acid, (2-bromophenyl)-, ethyl ester
• CAS NO: 104919-70-2
• Molecular Formula: C9H10BrNO2
• Molecular Weight: 244.088
• Mol File: 104919-70-2.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Carbamic acid, (2-bromophenyl)-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, (2-bromophenyl)-, ethyl ester(104919-70-2)
• EPA Substance Registry System: Carbamic acid, (2-bromophenyl)-, ethyl ester(104919-70-2)

Safety Data

• Hazardous Substances Data: 104919-70-2(Hazardous Substances Data)

Upstream product

• 541-41-3 chloroformic acid ethyl ester 
• 615-36-1 2-bromoaniline 
• 101-99-5 N-carboethoxyaniline 

Downstream Products

• 104919-72-4 ethyl N-[2-(1-butynyl)phenyl]carbamate 
• 1448422-99-8 ethyl (2-(3-hydroxy-3-methylbut-1-yn-1-yl)phenyl)carbamate 
• 148550-52-1 ethyl N-(2-ethynylphenyl)carbamate 
• 6832-87-7 2-bromo-N-methylaniline 
• 1295606-19-7 C₁₆H₁₆BrN₃O₂ 
• 851012-55-0 4-(2-Fluoro-phenyl)-1H-quinazolin-2-one 
• 1170354-33-2 C₂₀H₂₀BrNO₄ 
• 128643-12-9 (2-ethoxy-phenyl)-carbamic acid ethyl ester 
• 120-72-9 indole 
• 13307-67-0 ethyl 1H-indole-1-carboxylate 
• 104919-71-3 ethyl N-[2-(trimethylsilylethynyl)phenyl]carbamate 
• 104919-73-5 ethyl N-[(2-phenylethynyl)phenyl]carbamate 

Relevant articles and documents

Nickel(II)- And Silver(I)-Catalyzed C-H Bond Halogenation of Anilides and Carbamates

ortho -C-H bond halogenation of anilides and N -aryl carbamates using easily available N -halosuccinimides (NXS) as the active halogenation reagent in the presence of nickel or silver catalyst has been developed. This method provides a new approach to 2-haloanilides and carbamates, which may serve as starting materials for the synthesis of pharmaceutically and biologically active compounds.

1,7-palladium migration via C-H activation, followed by intramolecular amination: Regioselective synthesis of benzotriazoles

A novel 1,7-palladiummigration-cyclization-dealkylation sequence for the regioselective synthesis of benzotriazoles has been developed. These reactions proceed in excellent yields with high regioselectivities. The mechanism of the reaction has also been investigated.

Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders

This invention relates to compounds of the formula 1 wherein R1, R2, and R3 and R4 are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders.